![Ivan Møller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ivan Møller
Direttore operativo presso
ZEALAND PHARMA A/S
Patrimonio netto: 4 M $ in data 31/05/2026
Profilo
Ivan M.
Møller currently works at Zealand Pharma A, as Chief Operating Officer & Executive Vice President.
Mr. Møller also formerly worked at PolyPeptide Laboratories A, as Head-Production from 2002 to 2003, Novartis AG, as Global Head-Operations Management from 2017 to 2018, and Novartis Corp., as Vice President & Head-External Supply Organization from 2017 to 2018.
Mr. Møller received his graduate degree from Technical University of Denmark and Masters Business Admin degree in 2005 from Harvard Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ZEALAND PHARMA A/S 0,11% | 31/12/2025 | 78.587 ( 0,11% ) | 4 M $ | 31/05/2026 |
Posizioni attive di Ivan Møller
| Società | Posizione | Inizio |
|---|---|---|
| ZEALAND PHARMA A/S | Direttore operativo | 01/03/2018 |
Precedenti posizioni note di Ivan Møller
| Società | Posizione | Fine |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2018 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Corporate Officer/Principal | 01/01/2018 |
PolyPeptide Laboratories A/S
 PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries Manufactures polypeptides and custom peptide synthesis | Corporate Officer/Principal | 01/01/2003 |
Formazione di Ivan Møller
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
87
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PolyPeptide Laboratories A/S
PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries Manufactures polypeptides and custom peptide synthesis | Process Industries |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
